Danaher Co. (NYSE:DHR) Shares Acquired by AQR Capital Management LLC

AQR Capital Management LLC lifted its position in Danaher Co. (NYSE:DHR - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 376,906 shares of the conglomerate's stock after purchasing an additional 15,537 shares during the period. AQR Capital Management LLC owned about 0.05% of Danaher worth $86,519,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC lifted its stake in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of NYSE DHR traded down $1.58 during midday trading on Monday, hitting $197.47. The company had a trading volume of 1,181,680 shares, compared to its average volume of 3,365,513. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business has a 50-day simple moving average of $199.78 and a two-hundred day simple moving average of $221.43. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The firm has a market capitalization of $141.32 billion, a price-to-earnings ratio of 37.41, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were paid a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. This is an increase from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio is currently 24.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DHR. Citigroup reissued a "buy" rating on shares of Danaher in a research report on Monday, April 7th. The Goldman Sachs Group lowered their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a report on Friday, March 14th. Finally, Jefferies Financial Group reduced their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.